Wow, that's unbelievable. That's $200 million of taxpayers' money to fund a company owned by the Japanese in order to develop a vaccine that I understand had over 70% efficacy. It got developed knowing it couldn't be released. On top of that, it was contracted for about.... I don't know how many doses $770 million would buy at $20 a dose. That's probably about 10 doses per person in Canada.
We're on the hook for $150 million. They never produced a single vial of the vaccine, and you think that's good.
The Auditor General thought this was good efficacy, too. It goes to whether or not they did a value-for-money audit. I don't know how spending $773 million on a vaccine that could never be produced or exported is good value.
What is the motivation for the department to sign such a horrible deal, when we don't even own the IP? Now the Japanese own the IP, on top of everything else. Is that correct?